Symfo

Symfo, a leading provider of electronic patient reported outcome (ePRO) solutions for clinical trials, announced today the relocation of its U.S. corporate headquarters to Boston, Massachusetts to accommodate its recent growth.

The new office is conveniently located between Government Center and Park Street and will accommodate Symfo's expanding staff.

The new facility is just a few miles from the previous location and will allow Symfo to continue to maintain a strong presence in the East Coast area. In addition, the new office will continue to facilitate the relationships Symfo has formed with its US customers and partners.

"The new location is a convenient facility that serves to accommodate our continuing growth," said Serge Bodart, Symfo's CEO. "It reflects Symfo's commitment to develop and enhance customer support, customer service and operations for our clients."

Symfo's new address is:

Symfo (USA) Inc.
11 Beacon Street, Suite 1230
Boston, MA 02108
Tel (toll-free): 866-88-SYMFO
Tel (outside the U.S.): 617-577-9484

About Symfo
Symfo is an international organization specializing in electronic patient diary solutions, including the SymPro electronic patient diary, the SymQuest Palm-based diary and the SymVoice IVR. They are all simple to use and affordable solutions enabling study participants to easily implement electronic patient diaries in all phases of clinical trials and post-marketing studies.

Symfo's FDA-compliant handheld devices (SymPro & SymQuest) utilize Symfo's unique IDR system (Interactive Diary Response) – providing all the advantages of a handheld device (easy to carry, fits in your pocket) combined with simple, reliable phone-based data transfer. Symfo's IDR system guarantees 100% successful transmission of patient data – and works anywhere in the world.

For further details, please visit www.symfo.com.